There was a significant difference demonstrated in β2-M protein expression in the four breast cancer molecular subtypes (P < 0.05), and between the ER+ and ER− groups (P < 0.01); however, no significant difference was demonstrated between the HER-2+ and HER-2− groups. This evidence concerns the gene ESR1 and breast carcinoma.